Tvardi Therapeutics, Inc..
TVRD.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing highly selective STAT3 inhibitors for the treatment of cancer and fibrotic diseases. Their lead product candidate, TTI-101, is an orally administered, small molecule STAT3 inhibitor curr...Show More
Better Health for All
0
Tvardi Therapeutics is a clinical-stage biopharmaceutical company whose entire business is devoted to developing novel treatments for serious diseases like cancer and fibrosis, indicating a core strategy centered on health improvement.
1
The company's pipeline includes TTI-101 and TTI-109, oral STAT3 inhibitors for conditions such as idiopathic pulmonary fibrosis (IPF), hepatocellular carcinoma (HCC), and advanced cancers.
2
However, the Phase 2 REVERT trial for TTI-101 in IPF did not meet its goals, showing no statistically significant difference in forced vital capacity (FVC) improvement compared to placebo (41% for placebo vs. 39% and 44% for treated arms).
3
This trial also reported high discontinuation rates in treated arms (56.7% for 400mg, 62.1% for 800mg) compared to placebo (10.3%), primarily due to gastrointestinal adverse events.
4
The company has received significant funding for innovation, including $20 million in non-dilutive support, a $74 million Series B financing, and a $28 million private placement, all supporting clinical development and translational research.
5
Clinical trials are conducted as randomized, double-blind, placebo-controlled studies.
6
The company also received $5 million in funding to support an HCC prevention program.
7
Fair Money & Economic Opportunity
0
No evidence available to assess Tvardi Therapeutics, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No evidence available to assess Tvardi Therapeutics, Inc. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
No evidence was found in the provided articles regarding Tvardi Therapeutics, Inc.'s fair trade and ethical sourcing practices. The articles explicitly state they do not contain data on fair trade certifications, audit frequency, forced or child labor incidents, supply chain traceability, remediation speed, ethical clause coverage in contracts, materials risk index, or supplier diversity spend.
1
Honest & Fair Business
-40
The company has a Whistleblower Policy with a toll-free compliance hotline, and the Audit Committee is responsible for supervising and overseeing inquiries and investigations related to accounting, internal accounting controls, and auditing concerns.
1
However, there is no evidence of independent investigation processes beyond the Audit Committee's oversight. A standalone Anti-Corruption Policy is in place, providing guidance on FCPA and other anti-corruption laws.
2
but the articles do not specify the frequency or effectiveness metrics of training.
Kind to Animals
-50
Tvardi Therapeutics, Inc. engages in animal testing.
1
and conducts preclinical research studies.
2
No explicit animal welfare policy information is provided in the articles,
3
indicating an absence of a formal policy regarding animal testing practices.
No War, No Weapons
0
The company is a clinical-stage biopharmaceutical firm.
1
The provided articles, which primarily cover corporate governance and financial information, do not contain specific, measurable evidence for any of the KPIs under the 'No War, No Weapons' value. Therefore, no KPIs can be scored based on the strict evidence rules.
Planet-Friendly Business
0
The provided articles, which are primarily financial reports and company disclosures, do not contain specific, concrete data points or disclosures related to any of the 'Planet-Friendly Business' KPIs.
1
Information regarding environmental performance, emissions, renewable energy use, water management, waste diversion, green building certifications, supply chain climate transparency, biodiversity efforts, climate-related targets, or environmental compliance violations is not available.
2
Multiple articles explicitly state that sustainability data is unavailable or not disclosed for Tvardi Therapeutics, Inc.
3
Respect for Cultures & Communities
0
The company provides grievance mechanisms through a Chief Compliance Officer, a dedicated email address, and a toll-free compliance hotline.
1
An Open Door Policy is also available for reporting complaints regarding accounting and auditing matters.
2
The Chief Compliance Officer is responsible for investigating possible violations of the Code of Conduct.
3
New personnel receive training on the Code of Conduct policies, and annual training sessions are conducted to refresh familiarity, with completion implied by a required acknowledgment form.
4
Safe & Smart Tech
0
Tvardi Therapeutics allows users to opt-out of communications, request access, correction, deletion, or restriction of their information, withdraw consent, request data copies, and lodge complaints with a data protection authority.
1
The company's Audit Committee oversees compliance with legal and regulatory requirements, including those from the FDA and SEC, and reviews risks related to data privacy and cybersecurity.
2
Tvardi states it collects personal information considered necessary for its stated purposes, and its privacy policy, effective December 20, 2017, indicates it follows generally accepted industry standards for data security.
3
Zero Waste & Sustainable Products
0
No specific data points or facts regarding Tvardi Therapeutics (TVRD.US) related to waste diversion, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education were found in the provided articles.
1
The articles discuss general pharmaceutical waste management regulations and best practices, but do not offer company-specific performance data for TVRD.US.
2